These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31210312)

  • 1. MiRNA-621 inhibits the malignant progression of non-small cell lung cancer via targeting SIX4.
    Zhang M; Shi H; Zhang C; Zhang SQ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4807-4814. PubMed ID: 31210312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA HANR aggravates the progression of non-small cell lung cancer via mediating miRNA-140-5p.
    Li SJ; Wu YX; Liang YH; Gao Y; Wu AB; Zheng HY; Yang ZX
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):704-711. PubMed ID: 32016972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1.
    Xu ZL; Zhang M; Chen SX; Qiu M; Zhang Q; Gao LP; Li JDX
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8921-8930. PubMed ID: 31696479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2.
    Tan T; Xu XH; Lu XH; Wang XW
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIX4 acts as a master regulator of oncogenes that promotes tumorigenesis in non-small-cell lung cancer cells.
    Tang X; Yang Y; Song X; Liu X; Wang X; Huang F; Li Y; Chen F; Wan H
    Biochem Biophys Res Commun; 2019 Aug; 516(3):851-857. PubMed ID: 31266633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.
    Chen ZY; Liu HY; Jiang N; Yuan JM
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9939-9946. PubMed ID: 31799663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA TRERNA1 promotes malignant progression of NSCLC through targeting FOXL1.
    Luo DB; Lv HB; Sun XH; Wang Y; Chu JH; Salai AL
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1233-1242. PubMed ID: 32096153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol suppresses NSCLC cell growth, invasion and migration by mediating Wnt/β-catenin pathway via downregulating SIX4 and SPHK2.
    Wang X; Liu C; Wang J; Tian Z
    J Chemother; 2024 Sep; 36(5):411-421. PubMed ID: 37968995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-940 inhibits the progression of NSCLC by targeting FAM83F.
    Gu GM; Zhan YY; Abuduwaili K; Wang XL; Li XQ; Zhu HG; Liu CL
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5964-5971. PubMed ID: 30280778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-597 inhibits NSCLC progression through negatively regulating CDK2 expression.
    Yu DJ; Li YH; Zhong M
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4288-4297. PubMed ID: 32373965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-19a promotes proliferative and migratory abilities of NSCLC cells by inhibiting PTEN expression.
    Shi J; Han Y; Lin D; Wang K; Liu B; Gao C
    J BUON; 2019; 24(3):955-962. PubMed ID: 31424647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-199 inhibits malignant progression of lung cancer through mediating RGS17.
    Su WZ; Ren LF
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3390-3400. PubMed ID: 31081094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
    Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiRNA-153-3p promotes gefitinib-sensitivity in non-small cell lung cancer by inhibiting ATG5 expression and autophagy.
    Zhang W; Dong YZ; Du X; Peng XN; Shen QM
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2444-2452. PubMed ID: 30964170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA-217 inhibits proliferation of hepatocellular carcinoma cells by regulating KLF5.
    Gao W; Lu YX; Wang F; Sun J; Bian JX; Wu HY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7874-7883. PubMed ID: 31599412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
    Wang T; Li W; Li W; Liu L; Zhang H
    J BUON; 2019; 24(2):591-598. PubMed ID: 31128011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAGI1-IT1 stimulates proliferation in non-small cell lung cancer by upregulating AKT1 as a ceRNA.
    Zhang G; Chen HX; Yang SN; Zhao J
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):691-698. PubMed ID: 32016970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.